TMC Corporation (4169), operating in the biotechnology and healthcare sector, announced its financial performance for the fourth quarter of 2025. The company's basic Earnings Per Share (EPS) was NT$0.32. Total revenue for the quarter reached NT$685 million, and the net profit after tax was NT$19 million.

FACT BOX

  • Source: PR Times
  • Category: 調查